These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 4207590)

  • 1. Controlled trial of various anti-D dosages in suppression of Rh sensitization following pregnancy. Report to the Medical Research Council by the working party on the use of anti-D-immunoglobulin for the prevention of isoimmunization of Rh-negative women during pregnancy.
    Br Med J; 1974 Apr; 2(5910):75-80. PubMed ID: 4207590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of rhesus immunization in Australia. The first seven years.
    Davey MG
    Med J Aust; 1975 Aug; 2(7):263-7. PubMed ID: 808697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of Rh sensitization using anti-D immunoglobulin. (An 8 year study)].
    Spoljarić I; Majnarić M
    Jugosl Ginekol Opstet; 1978; 18(5-6):417-22. PubMed ID: 119891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rhesus sensitization and prevention with anti-D-immunoglobulin].
    Hindemann P; Hinselmann M; Frey P
    Gynaecologia; 1969; 167(5):276-9. PubMed ID: 4184763
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of Rh hemolytic disease of the newborn.
    Jennings ER; Dibbern HH; Hodell FH; Monroe CH; Peckham NH; Sullivan JF; Pollack W
    Calif Med; 1969 Feb; 110(2):130-3. PubMed ID: 4181977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The detection of anti-D in Rho (D)-negative infants born of Rho (D)-positive mothers.
    Bowen FW; Renfield M
    Pediatr Res; 1976 Apr; 10(4):213-5. PubMed ID: 818607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical aspects in the prevention of antibody formation with anti-D-immunoglobulin].
    Frey P; Hinselmann M; Hindemann P
    Gynaecologia; 1969; 167(5):280-4. PubMed ID: 4184764
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemolytic disease of the newborn due to anti-S-antibodies].
    Gligorović VN; Gligorović S; Veselinović I; Milosević M
    Bilt Hematol Transfuz; 1977; 5(1):51-7. PubMed ID: 411482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-D prevention. Review and outlook for 1976].
    Schneider J
    Fortschr Med; 1976 Nov; 94(31):1747-52. PubMed ID: 826466
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women].
    Liu KL; Li N; Li BJ; Peng JY; Shu XW; Yu YY
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):185-7. PubMed ID: 19292952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho (D) immune prophylaxis. A double-blind cooperative study.
    White CA; Visscher RD; Visscher HC; Wade ME
    Obstet Gynecol; 1970 Sep; 36(3):341-6. PubMed ID: 4988961
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prophylaxis of Rh-sensitisation by intravenous IgG anti-D (author's transl)].
    Börner P; Deicher H; Bähr I; Chelius HH; Ghani G; Geldmacher H; Henke IW; Kindermann L; Marks V
    Dtsch Med Wochenschr; 1977 May; 102(20):745-51. PubMed ID: 405190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ante-partum administration of preventive treatment of Rh-D immunization in rhesus-negative women. Parallel evaluation of transplacental passage of fetal blood cells. Results of a multicenter study carried out in the Paris region].
    Huchet J; Dallemagne S; Huchet C; Brossard Y; Larsen M; Parnet-Mathieu F
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):101-11. PubMed ID: 3035003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rh-prophylaxis with immunoglobulin anti-D administered during pregnancy and after delivery.
    Hermann M; Kjellman H
    Acta Obstet Gynecol Scand Suppl; 1976; 49():1-11. PubMed ID: 816170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between the presence of cytotoxic anti-HL-A antibodies in the clinical course of hemolytic disease of the newborn infant due to anti-Rh (D) or immune anti-A/B erythrocyte antibodies].
    Gligorović VN; Gligorović S; Susaković N; Lopicić L; Stolić I; Marković V; Matejić T
    Bilt Hematol Transfuz; 1976; 4(3):23-31. PubMed ID: 827283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prophylatic rhesus sensitization via intravenous administration of immunoglobulin G anti-D. III. Limits of the prophylaxsis obtainable by adapting the immunoglobulin dosage to the extent of the fetalmaternal blood transfusion (author's transl)].
    Börner P; Deicher H; Bähr I; Chalius HH; Ghani G; Geldmacher H; Henke IW; Kindermann L; Marks V
    Geburtshilfe Frauenheilkd; 1976 Jun; 36(6):485-92. PubMed ID: 820591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the enzyme test for the detection of clinically significant red blood cell antibodies during pregnancy.
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
    Acta Med Croatica; 1999; 53(3):125-8. PubMed ID: 10705633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successes and failures in rhesus-prophylaxis].
    Speiser P
    Wien Med Wochenschr; 1983 Dec; 133(23-24):595-604. PubMed ID: 6420993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.